Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORELearn more about this fast-acting pain relief solution for horses which is consistent, safe, and backed by Merck Animal Health.
LEARN MOREIndicated for management of chronic keratoconjunctivitis sicca and chronic superficial keratitis in dogs.
LEARN MORE